2021
DOI: 10.1016/j.annonc.2021.01.074
|View full text |Cite
|
Sign up to set email alerts
|

Exosome-based liquid biopsies in cancer: opportunities and challenges

Abstract: Liquid biopsy in cancer has gained momentum in clinical research and is experiencing a boom for a variety of applications. There are significant efforts to utilize liquid biopsies in cancer for early detection and treatment stratification, as well as residual disease and recurrence monitoring. Although most efforts have used circulating tumor cells and circulating tumor DNA for this purpose, exosomes and other extracellular vesicles have emerged as a platform with potentially broader and complementary applicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
419
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 554 publications
(421 citation statements)
references
References 130 publications
(163 reference statements)
0
419
0
2
Order By: Relevance
“…blood, lymph, cerebrospinal fluid, vitreous, interstitial fluids, etc.) 49, 58 . Furthermore, there is no evidence of adverse effects of allogeneic exosome transfer, whether of purified exosomes (from amniotic fluid, blood, etc.)…”
Section: Discussionmentioning
confidence: 99%
“…blood, lymph, cerebrospinal fluid, vitreous, interstitial fluids, etc.) 49, 58 . Furthermore, there is no evidence of adverse effects of allogeneic exosome transfer, whether of purified exosomes (from amniotic fluid, blood, etc.)…”
Section: Discussionmentioning
confidence: 99%
“…It 2as recently suggested that exosomes have several advantages over other biological components in liquid biopsies [44,45]. Indeed, among different moieties present in liquid biopsies, EV are stable in circulation and protect their cargos from degradation.…”
Section: Liquid Biopsiesmentioning
confidence: 99%
“…The DNA that is searched in this blood-based test is called circulating tumor DNA (ctDNA), because, as the name suggests, cancer cells release it into the peripheral blood from necrotic and apoptotic processes during carcinogenesis [11]. Moreover, it is also actively released from exosomes [12].…”
Section: Ctdna Methylation-sept9 Methylation Assaysmentioning
confidence: 99%